Lipids

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA Approval
FDA Sign
FDA Approval
FDA Approves Lerochol Autoinjector for Adults With Hypercholesterolemia, Updates LDL-C Labeling
08/19/2026
Anthony Calabro, MA
The FDA approved a once-monthly autoinjector for Lerochol (lerodalcibep-liga) and added language to the prescribing information noting that cardiovascular outcomes trials with statins and monoclonal...
08/19/2026
Lipids
Lipids
FDA Approves New Dosing Option for Praluent
04/25/2017
The FDA has approved a new, monthly dosing option for the PCSK9-inhibitor Praluent (alirocumab).
04/25/2017